Physician profile
Jonathan C Chang
NPI 1730391889
$1,742.89
in general payments reported to CMS, 2019-2025
9 companies · $364 in 2025
The $364 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $447 · 2020: $150 · 2021: $159 · 2022: $268 · 2023: $118 · 2024: $236 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $394.39 | 2024-2025 | Caplyta |
| Neurocrine Biosciences, INC. | $386.09 | 2021-2024 | Ingrezza |
| Sunovion Pharmaceuticals INC. | $382.43 | 2019-2022 | |
| Abbvie INC. | $249.08 | 2019-2024 | Vraylar |
| Teva Pharmaceuticals USA, INC. | $119.90 | 2019 | |
| Alkermes, INC. | $112.54 | 2019 | |
| Allergan, INC. | $66.78 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $18.62 | 2024 | Cobenfy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.